The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.
The World Health Organization (WHO) recommends leaving out Influenza B/Yamagata from flu shot compositions for the 2024 Southern Hemisphere season, as no confir
While the world stays on high alert as new COVID-19 variants crop up, India witnesses a surge in respiratory infections like H1N1, H3N2 and common cold. TheHealthSite.com
Respiratory viruses such as the novel human influenza virus (swine flu), H3N2, Victoria group, and respiratory syncytial virus (RSV) are causing a surge in illnesses resembling common cold symptoms. Official data shows that H3N2 infections account for 50% of all respiratory infections, followed by the Victoria group, RSV, and swine flu.